SuperworthEverQuote EVER
- Market cap
- $801.4M
- PE
- 7.4×
- 2y median 18.5×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.1×
- EV/EBIT
- 7.4×
- Revenue, 12 months
- $755.2M
- +23% on a year ago
- Net margin
- 15.2%
- Free cash flow yield
- 11.9%
EverQuote trades at 7.4× trailing earnings, cheaper than 80% of the last ten years. Revenue was $755.2M over the last twelve months, up 23% on a year earlier with a 15% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $55M−47% | $55.7M−37% | $91.1M−17% | $117.1M+72% | $144.5M+163% | $147.5M+165% | $166.6M+83% | $156.6M+34% | $173.9M+20% | $195.3M+33% | $190.9M+15% | $195.1M+25% | |
| Cost of revenue | $6.2M+5% | $5M−18% | $5M−13% | $5M−10% | $5.5M−11% | $5.4M+9% | $5.4M+7% | $4.8M−3% | $4.7M−14% | $4.4M−18% | $4.3M−21% | $4.4M−10% |
| Gross profit | $48.9M−50% | $50.7M−38% | $86M−17% | $112.1M+80% | $139.1M+185% | $142M+180% | $161.3M+88% | $151.8M+35% | $169.2M+22% | $190.9M+34% | $186.6M+16% | $190.7M+26% |
| R&D | $6.3M−20% | $5.9M−20% | $6.8M−14% | $7M−6% | $8M+28% | $7.6M+29% | $7.5M+9% | $7.8M+10% | $7.9M−1% | $8.3M+9% | $8.5M+14% | $9.4M+21% |
| SG&A | $52.2M−46% | $51.6M−38% | $77.4M−21% | $98.8M+53% | $119.4M+129% | $122.4M+137% | $137.9M+78% | $129.5M+31% | $143.7M+20% | $163.9M+34% | $154.6M+12% | $157.8M+22% |
| −$29.4M+346% | −$6.8M−22% | $1.8M | $6.3M | $11.7M | $12M | $8M+353% | $14.2M+125% | $17.5M+50% | $18.6M+55% | $23.4M+193% | $23.5M+66% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | −$29M+349% | −$6.4M−25% | $2.2M | $6.8M | $12.3M | $12.7M | $8.7M+296% | $15.1M+121% | $18.5M+51% | $19.6M+54% | $24.4M+181% | $24.5M+63% |
| $236K | −$23K | $286K+0% | $406K+421% | $719K+205% | $428K | $684K+139% | $363K−11% | −$345K | −$38.2M | $5.7M+732% | $5.3M+1367% | |
| Net income | −$29.2M+353% | −$6.3M−25% | $1.9M | $6.4M | $11.6M | $12.3M | $8M+319% | $14.7M+130% | $18.9M+63% | $57.8M+369% | $18.7M+134% | $19.2M+31% |
| −$0.87+335% | −$0.19−27% | $0.05 | $0.17 | $0.31 | $0.33 | $0.21+320% | $0.39+129% | $0.50+61% | $1.54+367% | $0.51+143% | $0.53+36% | |
| 33.5M+5% | 34M+5% | 35.6M+8% | 36.7M+11% | 37.2M+11% | 37.1M+9% | 37.7M+6% | 38M+4% | 37.7M+1% | 37.6M+2% | 36.9M−2% | 36.2M−5% |
Revenue: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them. 37 periods, Q2 FY17 to Q2 FY26: not printed by the filing, worked out from its own lines.
R&D: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
SG&A: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
Operating income: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
Net income: Q1 FY17 and Q1 FY18: 6 months less the 3 months printed beside them.
EPS, diluted: 9 periods, Q1 FY17 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY17 and Q1 FY18: share-days: the 6-month average less the second quarter's. 6 periods, Q4 FY18 to Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest EverQuote's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| EVEREverQuote | $801.4M | 7.4× | 18.5× | 1.1× | +23% | 15.2% | |
| TASKTaskUs | $784.8M | 7.4× | 26.3× | 0.6× | +11% | 8.8% | |
| YEXTYext | $727.5M | 38.7× | 48.3× | 1.6× | −1% | 5.9% | |
| MNTNMNTN | $724.1M | 12.9× | 15.1× | 2.3× | +21% | 18.0% | |
| NRDSNerdwallet | $698.7M | 12.3× | 15.9× | 0.8× | +12% | 7.6% | |
| IBEXIBEX | $627.1M | 15.1× | 11.5× | 1.0× | +15% | 7.2% | |
| HSTMHealthstream | $1B | 48.8× | 54.3× | 3.2× | +9% | 6.6% | |
| CARSCars.com | $585.6M | 19.2× | 27.3× | 0.8× | +1% | 4.7% | |
| OOMAOoma | $545.7M | 52.0× | 124× | 1.8× | +17% | 3.6% | |
| UPWKUpwork | $1.2B | 12.5× | 15.9× | 1.5× | +2% | 12.9% | |
| LZLegalzoom.Com | $1.2B | 77.7× | 68.5× | 1.5× | +12% | 2.1% | |
| Peer median | $725.8M | 17.1× | 26.8× | 1.5× | +11% | 6.9% |
More on EverQuote
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #3of 272Technology stocks with the lowest PE ratio
- #10of 296Technology stocks with the lowest EV/EBIT
- #2of 53Application software stocks with the lowest PE ratio
- #3of 41Application software stocks with the fastest earnings growth
- #6of 62Application software stocks with the lowest EV/EBIT
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .